Supplementary Figure 1-3 from Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial

作者：Allison Voisin, C. Terret, Camille Schiffler, Anne-Sophie Bidaux, Hélène Vanacker, Marlène Perrin-Niquet, Maud Barbery, Armelle Vinceneux, Lauriane Eberst, Pierre Stéphan, Gwenaële Garin, Dany Spaggiari, David Pérol, Yenkel Grinberg‐Bleyer, Philippe A. Cassier · 年份：2024 · DOI：10.1158/1078-0432.25826435 · 研究领域：Cancer, Stress, Anesthesia, and Immune Response、Pancreatic and Hepatic Oncology Research、Cancer Immunotherapy and Biomarkers

<p>Supplemetary figures S1, S2 and S3</p>